Sarah Romano - Net Worth and Insider Trading
Sarah Romano Net Worth
The estimated net worth of Sarah Romano is at least $54,717 dollars as of 2024-05-21. Sarah Romano is the CFO of Entero Therapeutics Inc and owns about 19,111 shares of Entero Therapeutics Inc (ENTO) stock worth over $54,466. Sarah Romano is also the CFO of Kiora Pharmaceuticals Inc and owns about 437 shares of Kiora Pharmaceuticals Inc (KPRX) stock worth over $251. Details can be seen in Sarah Romano's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Sarah Romano has not made any transactions after 2024-04-01 and currently still holds the listed stock(s).
Transaction Summary of Sarah Romano
Sarah Romano Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sarah Romano owns 2 companies in total, including Kiora Pharmaceuticals Inc (KPRX) , and First Wave BioPharma Inc (FWBI) .
Click here to see the complete history of Sarah Romano’s form 4 insider trades.
Insider Ownership Summary of Sarah Romano
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KPRX | Kiora Pharmaceuticals Inc | 2019-11-05 | Chief Financial Officer |
| FWBI | First Wave BioPharma Inc | 2024-04-01 | Chief Financial Officer |
Sarah Romano Latest Holdings Summary
Sarah Romano currently owns a total of 2 stocks. Among these stocks, Sarah Romano owns 19,111 shares of Entero Therapeutics Inc (ENTO) as of April 1, 2024, with a value of $54,466 and a weighting of 99.54%. Sarah Romano also owns 437 shares of Kiora Pharmaceuticals Inc (KPRX) as of July 15, 2019, with a value of $251 and a weighting of 0.46%.
Latest Holdings of Sarah Romano
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ENTO | Entero Therapeutics Inc | 2024-04-01 | 19,111 | 2.85 | 54,466 |
| KPRX | Kiora Pharmaceuticals Inc | 2019-07-15 | 437 | 0.57 | 251 |
Holding Weightings of Sarah Romano
Sarah Romano Form 4 Trading Tracker
According to the SEC Form 4 filings, Sarah Romano has made a total of 5 transactions in Entero Therapeutics Inc (ENTO) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Entero Therapeutics Inc is the sale of 75 shares on April 1, 2024, which brought Sarah Romano around $317.
According to the SEC Form 4 filings, Sarah Romano has made a total of 1 transactions in Kiora Pharmaceuticals Inc (KPRX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Kiora Pharmaceuticals Inc is the sale of 33 shares on July 15, 2019, which brought Sarah Romano around $4,740.
Insider Trading History of Sarah Romano
- 1
Sarah Romano Trading Performance
GuruFocus tracks the stock performance after each of Sarah Romano's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sarah Romano is 15.34%. GuruFocus also compares Sarah Romano's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sarah Romano within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Sarah Romano's insider trading performs compared to the benchmark.
Performance of Sarah Romano
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 29.1 | | | | | |
| Relative Return to S&P 500(%) | 27.65 | | | | | |
Sarah Romano Ownership Network
Sarah Romano Owned Company Details
What does Kiora Pharmaceuticals Inc do?
Who are the key executives at Kiora Pharmaceuticals Inc?
Sarah Romano is the Chief Financial Officer of Kiora Pharmaceuticals Inc. Other key executives at Kiora Pharmaceuticals Inc include EVP of Finance Melissa Tosca , Interim CFO Susan L. Drexler , and director & President and CEO Brian M. Strem .
Kiora Pharmaceuticals Inc (KPRX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Kiora Pharmaceuticals Inc (KPRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kiora Pharmaceuticals Inc (KPRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Kiora Pharmaceuticals Inc (KPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kiora Pharmaceuticals Inc Insider Transactions
Sarah Romano Mailing Address
Above is the net worth, insider trading, and ownership report for Sarah Romano. You might contact Sarah Romano via mailing address: 271 Waverly Oaks Road, Waltham Ma 02452.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
